At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
ELAB PMGC Holdings
Pre-Mkt 10-15 04:18:22 EDT
2.97
+0.01
+0.34%
High3.07Low2.96Vol11.19K
Open3.01D1 Closing2.96Amplitude3.72%
Mkt Cap2.40MTradable Cap2.27MTotal Shares809.58K
T/O34.04KT/O Rate1.46%Tradable Shares764.19K
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

PMGC Holdings Adopts NorthStrive Holdings Name Under DBA Rebrand
Reuters  ·  10-08
PMGC Holdings Adopts NorthStrive Holdings Name Under DBA Rebrand
Pmgc - Northstrive Holdings to Operate Under Dba Name Effective Immediately
THOMSON REUTERS  ·  10-08
Pmgc - Northstrive Holdings to Operate Under Dba Name Effective Immediately
Pmgc Holdings Inc. Announces Dba as Northstrive Holdings, Inc., Trademark License Agreement, and Website Update
THOMSON REUTERS  ·  10-08
Pmgc Holdings Inc. Announces Dba as Northstrive Holdings, Inc., Trademark License Agreement, and Website Update
Pmgc - Northstrive Holdings Plans Formal Legal Name Change Within Six Months
THOMSON REUTERS  ·  10-08
Pmgc - Northstrive Holdings Plans Formal Legal Name Change Within Six Months
Pmgc - NASDAQ Ticker Symbol and Existing Filings Remain Unchanged
THOMSON REUTERS  ·  10-08
Pmgc - NASDAQ Ticker Symbol and Existing Filings Remain Unchanged
PMGC Launches NorthStrive SPAC Sponsorship Platform with $100 Million NSAI IPO
Reuters  ·  10-01
PMGC Launches NorthStrive SPAC Sponsorship Platform with $100 Million NSAI IPO
Pmgc - Holds 2.7 Mln Shares, 21.4% of Northstrive Acquisition Corp I Class a Shares
THOMSON REUTERS  ·  10-01
Pmgc - Holds 2.7 Mln Shares, 21.4% of Northstrive Acquisition Corp I Class a Shares
Pmgc Holdings (Nasdaq: Elab) Announces Completion of $100 Million SPAC IPO, Launching Northstrive Acquisition Corp. I (Nasdaq: Nsai) as First in Planned SPAC Sponsorship Franchise to Expand M&a Strategy
THOMSON REUTERS  ·  10-01
Pmgc Holdings (Nasdaq: Elab) Announces Completion of $100 Million SPAC IPO, Launching Northstrive Acquisition Corp. I (Nasdaq: Nsai) as First in Planned SPAC Sponsorship Franchise to Expand M&a Strategy
PMGC Unit Working With Charles River Laboratories for Muscle Health Probiotic Testing
MT Newswires Live  ·  09-29
PMGC Unit Working With Charles River Laboratories for Muscle Health Probiotic Testing
PMGC Unit NorthStrive Biosciences Partners with Charles River to Advance EL-22, EL-32 Programs
Reuters  ·  09-29
PMGC Unit NorthStrive Biosciences Partners with Charles River to Advance EL-22, EL-32 Programs
PMGC Secures Five-Year Royalty Payment Plan from Elevai Skincare Sale Through August 2031
Reuters  ·  09-18
PMGC Secures Five-Year Royalty Payment Plan from Elevai Skincare Sale Through August 2031
Pmgc Holdings Inc. (Nasdaq: Elab) Secures Five-Year Royalty Stream from Elevai Skincare Sale Under Executed Payment Agreement with Longevity Health Holdings
THOMSON REUTERS  ·  09-18
Pmgc Holdings Inc. (Nasdaq: Elab) Secures Five-Year Royalty Stream from Elevai Skincare Sale Under Executed Payment Agreement with Longevity Health Holdings
Pmgc - 5% Net Sales Royalty Converted to Scheduled Monthly Payments Through August 2031
THOMSON REUTERS  ·  09-18
Pmgc - 5% Net Sales Royalty Converted to Scheduled Monthly Payments Through August 2031
PMGC Holdings advances AI-driven cardiometabolic expansion program
TIPRANKS  ·  09-03
PMGC Holdings advances AI-driven cardiometabolic expansion program
U.S. Stocks on the MOVE-GoPro, TXNM Energy, Emergent BioSolutions
Reuters  ·  09-01
U.S. Stocks on the MOVE-GoPro, TXNM Energy, Emergent BioSolutions
PMGC Unit NorthStrive Biosciences Expands AI Drug Discovery Program with Yuva Biosciences
Reuters  ·  09-01
PMGC Unit NorthStrive Biosciences Expands AI Drug Discovery Program with Yuva Biosciences
Northstrive Biosciences - Amendment Grants Co Right of First Refusal for Exclusive License in Cardiometabolic Field
THOMSON REUTERS  ·  09-01
Northstrive Biosciences - Amendment Grants Co Right of First Refusal for Exclusive License in Cardiometabolic Field
Northstrive Biosciences Expands AI-Driven Drug Discovery Program with Yuva Biosciences, Advancing Four Novel AI-Discovered Compounds Toward Lead Nomination for Potential Cardiac Disease and Obesity Therapeutic Applications
THOMSON REUTERS  ·  09-01
Northstrive Biosciences Expands AI-Driven Drug Discovery Program with Yuva Biosciences, Advancing Four Novel AI-Discovered Compounds Toward Lead Nomination for Potential Cardiac Disease and Obesity Therapeutic Applications
Northstrive Biosciences - Expansion Program Expected to Take 6 Months and Culminate in Lead Compound Nomination
THOMSON REUTERS  ·  09-01
Northstrive Biosciences - Expansion Program Expected to Take 6 Months and Culminate in Lead Compound Nomination
PMGC Plans CAD 200,000 Orbit2Orbit Share Subscription at CAD 0.8 Per Share
Reuters  ·  08-28
PMGC Plans CAD 200,000 Orbit2Orbit Share Subscription at CAD 0.8 Per Share

Introduction

Company Name.
PMGC Holdings
Affiliated Markets:
NASDAQ
Listing Date:
--
Main Business:
Elevai Labs, Inc., a skincare development company, designs, manufactures, and markets skincare products. Its products include Empower and Enfinity post-skincare procedure care serums for the face, neck, and upper chest regions. The company was formerly known as Reactive Medical Labs Inc. and changed its name to Elevai Labs, Inc. in December 2021. Elevai Labs, Inc. was incorporated in 2020 and is based in Newport Beach, California.
Issue price:
--